{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Han D"],"funding":["Shenyang Science and Technology Project"],"pagination":["e2482"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11220501"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(7)"],"pubmed_abstract":["<h4>Background</h4>Marfan syndrome (MFS) is a hereditary connective tissue disorder involving multiple systems, including ophthalmologic abnormalities. Most cases are due to heterozygous mutations in the fibrillin-1 gene (FBN1). Other associated genes include LTBP2, MYH11, MYLK, and SLC2A10. There is significant clinical overlap between MFS and other Marfan-like disorders.<h4>Purpose</h4>To expand the mutation spectrum of FBN1 gene and validate the pathogenicity of Marfan-related genes in patients with MFS and ocular manifestations.<h4>Methods</h4>We recruited 318 participants (195 cases, 123 controls), including 59 sporadic cases and 88 families. All patients had comprehensive ophthalmic examinations showing ocular features of MFS and met Ghent criteria. Additionally, 754 cases with other"],"journal":["Molecular genetics & genomic medicine"],"pubmed_title":["Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation."],"pmcid":["PMC11220501"],"funding_grant_id":["RC210438"],"pubmed_authors":["Liu Z","Yang Z","Li J","Chen Y","Chen X","Han D","Wang Z","Tian P"],"additional_accession":[]},"is_claimable":false,"name":"Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation.","description":"<h4>Background</h4>Marfan syndrome (MFS) is a hereditary connective tissue disorder involving multiple systems, including ophthalmologic abnormalities. Most cases are due to heterozygous mutations in the fibrillin-1 gene (FBN1). Other associated genes include LTBP2, MYH11, MYLK, and SLC2A10. There is significant clinical overlap between MFS and other Marfan-like disorders.<h4>Purpose</h4>To expand the mutation spectrum of FBN1 gene and validate the pathogenicity of Marfan-related genes in patients with MFS and ocular manifestations.<h4>Methods</h4>We recruited 318 participants (195 cases, 123 controls), including 59 sporadic cases and 88 families. All patients had comprehensive ophthalmic examinations showing ocular features of MFS and met Ghent criteria. Additionally, 754 cases with other","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jul","modification":"2026-05-29T11:45:10.919Z","creation":"2025-04-04T12:21:23.098Z"},"accession":"S-EPMC11220501","cross_references":{"pubmed":["38958168"],"doi":["10.1002/mgg3.2482"]}}